[Correlation between the T, K and NK cell count and the IgE level in patients with atopy (pollinosis)]. 1983

I S Gushchin, and V P Leskov, and V G Chitaeva, and O V Polsacheva, and Iu A Poroshina

In a homogenous group of patients with polyposis, IgE level was juxtaposed to the number of E-rosette-forming cells (E-RFC), K- and NK-cells. The effect of a parenterally introduced allergen (via an accelerated course hyposensibilization) was also determined upon those indices. The number of E-RFC was diminished in the patient group (53,1 +/- 3,3%) as compared with the results (67,2 +/- 2,1%) obtained from the control subjects, selected by the control method of couples. A dependence of a direct ratio was found between the number of E-RFC and IgE level in the patients. The number of K- and NK-cells in the patients did not significantly differ from their number in the control subjects; no relationship was found between the number of K-cells and the number of NK-cells, between those cells and IgE level or the number of E-RFC. Allergen-specific cells - kilers were present in the peripheral blood of the patients with polyposis. The course of specific hyposensibilization carried out was accompanied, in all patients by increased number of E-RFC (to 122 +/- 7% as compared with the initial level) and a reduction of the number of K-cells (to 36 +/- 5.4% as compared with the initial level). Both the changes in IgE level and the number of NK-cells were not of one type in all patients.

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D005260 Female Females
D006255 Rhinitis, Allergic, Seasonal Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS. Hay Fever,Pollen Allergy,Pollinosis,Seasonal Allergic Rhinitis,Hayfever,Allergic Rhinitides, Seasonal,Allergic Rhinitis, Seasonal,Allergies, Pollen,Allergy, Pollen,Fever, Hay,Pollen Allergies,Pollinoses,Rhinitides, Seasonal Allergic,Rhinitis, Seasonal Allergic,Seasonal Allergic Rhinitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I S Gushchin, and V P Leskov, and V G Chitaeva, and O V Polsacheva, and Iu A Poroshina
February 1981, Mykosen,
I S Gushchin, and V P Leskov, and V G Chitaeva, and O V Polsacheva, and Iu A Poroshina
January 1977, Otolaryngologia polska = The Polish otolaryngology,
I S Gushchin, and V P Leskov, and V G Chitaeva, and O V Polsacheva, and Iu A Poroshina
April 2010, International journal of dermatology,
I S Gushchin, and V P Leskov, and V G Chitaeva, and O V Polsacheva, and Iu A Poroshina
April 1991, The European respiratory journal. Supplement,
I S Gushchin, and V P Leskov, and V G Chitaeva, and O V Polsacheva, and Iu A Poroshina
March 2022, BMC pediatrics,
I S Gushchin, and V P Leskov, and V G Chitaeva, and O V Polsacheva, and Iu A Poroshina
October 1977, Lancet (London, England),
I S Gushchin, and V P Leskov, and V G Chitaeva, and O V Polsacheva, and Iu A Poroshina
April 1990, The Journal of allergy and clinical immunology,
I S Gushchin, and V P Leskov, and V G Chitaeva, and O V Polsacheva, and Iu A Poroshina
December 2016, Asian Pacific journal of allergy and immunology,
I S Gushchin, and V P Leskov, and V G Chitaeva, and O V Polsacheva, and Iu A Poroshina
January 2024, The journal of allergy and clinical immunology. In practice,
I S Gushchin, and V P Leskov, and V G Chitaeva, and O V Polsacheva, and Iu A Poroshina
January 1985, International archives of allergy and applied immunology,
Copied contents to your clipboard!